Nordea Investment Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Nordea Investment Management’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-10,500	Closed	-$354K	–	955
2014 Q4	$354K	Sell	10,500 -1,300	-11%	-$45.9K	﹤0.01%	628
2014 Q3	$413K	Buy	11,800 +300	+3%	+$10.3K	﹤0.01%	613
2014 Q2	$378K	Hold	11,500	–	–	﹤0.01%	701
2014 Q1	$424K	Sell	11,500 -35,000	-75%	-$1.28M	﹤0.01%	660
2013 Q4	$1.78M	Sell	46,500 -34	-0.1%	-$1.07K	0.01%	456
2013 Q3	$1.27M	Sell	46,534 -156,186	-77%	-$3.7M	0.01%	532
2013 Q2	$4.26M	Buy	+202,720	New	+$3.96M	0.03%	300

Other funds holding WX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.59B AUM 12.96% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

ACM

Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

Nordea Investment Management's WX Position: Q1 2015 in Review

Nordea Investment Management sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q1 2015, closing a stake of 10,500 shares — an estimated $354K sold.

Nordea Investment Management first reported a position in WX in Q2 2013 and held it in 7 quarters. The position peaked at $4.26M in Q2 2013. 147 funds tracked by Wall St. Rank hold WX as of Q1 2015.

Nordea Investment Management reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q1 2015 after selling out during the quarter.
Nordea Investment Management sold 10,500 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q1 2015, an estimated $354K.
Nordea Investment Management first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 7 quarters.
Nordea Investment Management's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $4.26M in Q2 2013.
147 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q1 2015.

Based on Nordea Investment Management's 13F filing for Q1 2015, filed 24 Apr 2015.